Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 9
Author(s): A.V. Zholos
Affiliation:
Export Options
About this article
Cite this article as:
Zholos A.V. , Meet Our Editorial Board Member, Current Neuropharmacology 2018; 16 (9) . https://dx.doi.org/10.2174/1570159X1609181005102719
DOI https://dx.doi.org/10.2174/1570159X1609181005102719 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
24
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles
Current Pharmaceutical Biotechnology Late Sodium Current is a New Therapeutic Target to Improve Contractility and Rhythm in Failing Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry Inhibitory Activity of Curcumin Derivatives Towards Metal-Free and Metal-Induced Amyloid-β Aggregation
Current Alzheimer Research MicroRNA-16-5p Aggravates Myocardial Infarction Injury by Targeting the Expression of Insulin Receptor Substrates 1 and Mediating Myocardial Apoptosis and Angiogenesis
Current Neurovascular Research Evaluation of [11C]S14506 and [18F]S14506 in Rat and Monkey as Agonist PET Radioligands for Brain 5-HT1A Receptors
Current Radiopharmaceuticals Target Prediction of Small Molecules with Information of Key Molecular Interactions
Current Topics in Medicinal Chemistry Editorial [Hot Topic:Perspective on Mild Cognitive Impairment (MCI) (Guest Editor: Bernardino Ghetti)]
Current Alzheimer Research Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Current Pharmaceutical Design Psychological and Mental Health Issues During the SARS-CoV-2 Global Pandemic: A Critical Analysis
Coronaviruses The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice
Current Neuropharmacology Pharmacogenetics in Treatment of Rheumatoid Arthritis
Current Pharmaceutical Design Vascular Morphology has No Direct Relationship with Atherosclerotic Plaque Burden in Patients with Symptomatic Middle Cerebral Artery Stenosis
Current Neurovascular Research Editorial [Hot Topic: Glutamate Receptors and Related Processes as Drug Targets (Guest Editor: Michel Baudry)]
Current Drug Targets Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry The Promotional Effect of Mesenchymal Stem Cell Homing on Bone Tissue Regeneration
Current Stem Cell Research & Therapy Adverse Effects and Drug Interactions of Biologic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments
Current Psychopharmacology Efficacy of Duloxetine in Patients with Chronic Pain Conditions
Current Drug Therapy Cardioprotection Acquired Through Exercise: The Role of Ischemic Preconditioning
Current Cardiology Reviews Synergistic Effect of Curcumin: A Review
Current Bioactive Compounds